On Wednesday, Inspire Medical Systems (INSP) hit a key performance benchmark, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 81, up from 72 the day before.
↑ XIBD's unique RS Rating identifies technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research shows that the best stocks often have an 80 or higher RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
Inspire Medical Systems is working on a consolidation with a 225.00 entry. See if it can break out in heavy trade.
The company showed 0% earnings growth in its most recent report. Revenue increased 33%.
Inspire Medical Systems earns the No. 9 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), Penumbra (PEN) and Boston Scientific (BSX) are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。